 | • レポートコード：MRC2303K040 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界の消化器科外来手術センター市場規模が、予測期間中（2022年-2027年）、CAGR 7％で増大すると予測されています。本レポートでは、消化器科外来手術センターの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、サービス別（診断サービス、手術サービス）分析、所有別（病院付属型、独立型、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、Alfa Surgery Center, LLC、Becton, Dickison and company、Hill-Rom Holdings、GE healthacre、Koninklijke PhilipsN.V、Medtronic、Gastro Health LLC、Ohio Gastroeneterology Group Inc、Ontario Advanced Surgery Center、Universal Health Services Incなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の消化器科外来手術センター市場規模：サービス別 - 診断サービスの市場規模 - 手術サービスの市場規模 ・世界の消化器科外来手術センター市場規模：所有別 - 病院付属型消化器科外来手術センターの市場規模 - 独立型消化器科外来手術センターの市場規模 - その他消化器科外来手術センターの市場規模 ・世界の消化器科外来手術センター市場規模：地域別 - 北米の消化器科外来手術センター市場規模 アメリカの消化器科外来手術センター市場規模 カナダの消化器科外来手術センター市場規模 メキシコの消化器科外来手術センター市場規模 … - ヨーロッパの消化器科外来手術センター市場規模 ドイツの消化器科外来手術センター市場規模 イギリスの消化器科外来手術センター市場規模 フランスの消化器科外来手術センター市場規模 … - アジア太平洋の消化器科外来手術センター市場規模 中国の消化器科外来手術センター市場規模 日本の消化器科外来手術センター市場規模 インドの消化器科外来手術センター市場規模 … - 南米/中東の消化器科外来手術センター市場規模 南アフリカの消化器科外来手術センター市場規模 ブラジルの消化器科外来手術センター市場規模 アルゼンチンの消化器科外来手術センター市場規模 … ・競争状況 ・市場機会・将来動向 |
The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).
The COVID-19 pandemic seemed to negatively impact the market’s growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff—also, prioritizing only the emergency cases negatively impacted the market’s growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market’s growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.
The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market’s growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market’s growth.
Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market’s growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data published in June 2021, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. Other driving factors include the rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies. For instance, as of August 2022, there were around 35967 ongoing clinical trials related to gastrointestinal diseases across different phases of development, as per the National Clinical Trial (NCT) registry. The positive outcomes from these studies can create new opportunities for an increase in gastroenterology ambulatory surgery center over the forecast period.
Thus, due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.
Gastroenterology Ambulatory Surgery Center Market Trends
The Freestanding Segment is Expected to Hold a Major Market Share in the Gastroenterology Ambulatory Surgery Center Market
The freestanding segment is expected to hold a dominating share in the growth of the market during the forecast period. The freestanding ownership segment, which mainly comprises physician-owned ambulatory surgery centers, is expected to account for the maximum share owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows the physicians to focus on a small number of procedures in a single setting. Endoscopic Ambulatory Service Centers are freestanding facilities designed to carry out gastrointestinal procedures at a low cost. Such beneficial characteristics of the freestanding ownership segment led to the increasing demand for the same among the patients, which allowed the manufacturers to implement various market strategies for market growth. In addition, the incidence and prevalence of ulcerative colitis (UC) have been reported to be rising in newly industrialized regions. According to a research study published in July 2020 titled ‘Review of the Epidemiology and Burden of Ulcerative Colitis in Latin America’, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000. Therefore, the research and studies show the increasing incidence and prevalence of the Ulcerative Colitis condition, and this is generating demand for the segment.
Thus due to these factors, the studied segment is expected to grow during the forecast period.
North America is Expected to Hold a Significant Share in the Market and is expected to do the Same in the Forecast Period.
The United States is expected to command the global market due to the high incidence of Gastroenterology problems and the high adoption rate of ambulatory surgical centers. For instance, According to the study published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, 60 to 70 million people suffer from gastrointestinal diseases every year in the United States. Additionally, the strong presence of ambulatory surgical centers in the region contributes to the market’s growth. For instance, according to the data published by the Medicare Payment Advisory Commission in 2020, the number of active ambulatory surgical centers in the United States is more than 9,280. Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region with dominating share.
Similarly, the innovative product launches to meet the growing demand for gastroenterology ambulatory surgical center services. For instance, in January 2020, Pentax Medical announced that it had received United States Food and Administration (FDA) 510 (K) clearance for its Imagina Endoscopy System, an innovative endoscopy platform for gastrointestinal (GI) procedures at ambulatory surgery centers. Additionally, an increase in research and development activities and favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.
Gastroenterology Ambulatory Surgery Center Market Competitor Analysis
The Gastroenterology Ambulatory Surgery Center Market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some of the companies which are currently dominating the market are Alfa Surgery Center, LLC, Becton, Dickison and Company, Hill- Rom Holdings, GE Healthcare, Koninklijke Philips N.V, Cook Medical, Medtronic, Gastro Health LLC, Ohio Gastroenterology Group Inc, Ontario Advanced Surgery Center, Universal Health Services Inc., and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing incidences of gastrointestinal diorders
4.2.2 Rising preferences for ambulatory services
4.3 Market Restraints
4.3.1 Regulatory uncertainaties
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Services
5.1.1 Diagnostic Services
5.1.2 Surgical Services
5.2 By Ownership
5.2.1 Hospital-Affiliated
5.2.2 Freestanding
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alfa Surgery Center, LLC
6.1.2 Becton, Dickison and company
6.1.3 Hill-Rom Holdings
6.1.4 GE healthacre
6.1.5 Koninklijke PhilipsN.V
6.1.6 Medtronic
6.1.7 Gastro Health LLC
6.1.8 Ohio Gastroeneterology Group Inc
6.1.9 Ontario Advanced Surgery Center
6.1.10 Universal Health Services Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS